The UALCAN online website (http://ualcan.path.uab.edu/index.html) presented the UNC5A proteomics data in GBM to identify the expression differences in gliomas and normal samples (p < 0.001; Fig. 3A), in different genders (p < 0.001; Fig. 3B), ages (p < 0.001; Fig. 3C), weight (p < 0.001; Fig. 3D) situations, and in different HIPPO and mTOR pathway statuses (p < 0.001; Fig. 3E, F) through CPTAC analysis. The gene discussed is UNC5A; the disease is central nervous system cancer.